Gilenya: What is it and How Does it Work? - National MS Society
This video features part one of a two-part interview with Aaron Miller, MD, who discusses Gilenya, a new oral therapy for multiple sclerosis. This video was produced in November 2010. In April of 2012 the FDA revised the prescribing information for Gilenya. Please visit www.nationalMSsociety.org/meds for the most updated information. To learn more about Gilenya and other disease modifying therapy options, download the Consensus on Disease Modifying Therapies online at www.nationalmssociety.org/DMTconsensus.
Видео Gilenya: What is it and How Does it Work? - National MS Society канала NationalMSSociety
Видео Gilenya: What is it and How Does it Work? - National MS Society канала NationalMSSociety
Показать
Комментарии отсутствуют
Информация о видео
Другие видео канала
What You Need to Know About Gilenya® (Fingolimod)
Invisible Symptoms in MS Part 1 - National MS Society
Employment and MS
What You Need to Know About Ocrevus
Gait and MS Part 1 - National MS Society
أ.د.عمرو حسن الحسني أستاذ المخ والأعصاب-Multiple Sclerosis
Walking and MS - Ben Thrower, M.D. - MSFocus at Sea 2019
What You Need to Know About Natalizumab (Tysabri®)
Mood Changes in MS
Recent Advances in the Treatment of Multiple Sclerosis: Are We There Yet?
What You Need To Know About Tecfidera®
Looking at Long Term Results of Fingolimod
MS and Pain - Ben Thrower, M.D. - January 2016
MS and COVID-19 What We Have learned So Far - Prof Gavin Giovannoni
What You Need To Know About Glatiramer Acetate (Copaxone®, Glatopa™)
Diagnosing MS - Lumbar puncture
Fingolimod or FTY720 MOA
At work with MS - Andrew Blacker, Police constable
Bladder and Bowel Dysfuction in MS - Tracy Walker, N.P. - July 2017
Mood Changes and MS: Practical Ways to Deal with Mood Swings - National MS Society